1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • De La Torre Tarazona E, Passaes C, Moreno S, Sáez-Cirión A, Alcamí J.

    High concentrations of Maraviroc do not alter immunological and metabolic parameters of CD4 T cells.

    Scientific Reports . 14(1): 13980-13980. Nº de citas: 4

    [doi:10.1038/s41598-024-64902-y]

  • Bueno-Díaz C, Zuurveld M, Ayechu-Muruzabal V, Korsten SGPJ, Martín-Pedraza L, Parrón-Ballesteros J, Redegeld F, Garssen J, Villalba M, Willemsen LEM.

    Mustard seed major allergen Sin a1 activates intestinal epithelial cells and also dendritic cells that drive type 2 immune responses.

    Food & Function . 15(12): 6488-6501. Nº de citas: 5

    [doi:10.1039/d4fo01980f]

  • Corbacho-Loarte MD, Martín O, Chamorro-Tojeiro S, Crespillo-Andújar C, Norman FF, Pérez-Molina JA, Sanz MG, Cancio-Suárez MR, Ruiz-Calvo G, López AR, Rubio JM, López-Vélez R, Monge-Maillo B.

    Screening blood donors for malaria, can we increase the number of eligible donors? An observational retrospective study.

    MALARIA JOURNAL . 23(1): 179-179. Nº de citas: 3

    [doi:10.1186/s12936-024-04966-3]

  • Weitzel T, Brown A, Libman M, Perret C, Huits R, Chen L, Leung D, Leder K, Connor BA, Menéndez MD, Asgeirsson H, Schwartz E, Salvador F, Malvy D, Saio M, Norman FF, Amatya B, Duvingnaud A, Vaughan S, Glynn M, Angelo KM.

    Intestinal protozoa in returning travellers: a GeoSentinel analysis from 2007 to 2019.

    JOURNAL OF TRAVEL MEDICINE . 31(4): . Nº de citas: 9

    [doi:10.1093/jtm/taae010]

  • Hidalgo-Tenorio C, Sequera S, Vivancos MJ, Vinuesa D, Collado A, Santos IL, Sorni P, Cabello-Clotet N, Montero M, Font CR, Terron A, Galindo MJ, Martinez O, Ryan P, Omar-Mohamed M, Albendín-Iglesias H, Javier R, Ruz MÁL, Romero A, Garcia-Vallecillos C.

    Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial.

    International Journal of Antimicrobial Agents . 63(6): 107164-107164. Nº de citas: 16

    [doi:10.1016/j.ijantimicag.2024.107164]

  • Albasata H, Gioia F, Jiang Y, Poutanen SM, Hosseini-Moghaddam SM.

    Outcome of Pneumocystis pneumonia in transplant and non-transplant HIV-negative immunocompromised patients.

    Transplant Infectious Disease . 26(5): . Nº de citas: 5

    [doi:10.1111/tid.14321]

  • Serrano-Villar S, Martínez E.

    The Gut Microbiome: Another Piece in the Puzzle of HIV-Associated Atherosclerosis.

    JOURNAL OF INFECTIOUS DISEASES . : .

    [doi:10.1093/infdis/jiae244]

  • Moreno C, Izquierdo R, Alejos B, Hernando V, Pérez de la Cámara S, Peraire J, Macías J, Bernal E, Albendín-Iglesias H, Alcaraz B, Suárez-García I, Moreno S, Jarrín I.

    Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain.

    AIDS PATIENT CARE AND STDS . 38(7): 305-314. Nº de citas: 10

    [doi:10.1089/apc.2024.0093]

  • Orkin C, Antinori A, Rockstroh JK, Moreno-Guillén S, Martorell CT, Molina JM, Lazzarin A, Maggiolo F, Yazdanpanah Y, Andreatta K, Huang H, Hindman JT, Martin H, Pozniak A.

    Switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir-based therapy: 96-week pooled analysis.

    AIDS . 38(7): 983-991. Nº de citas: 18

    [doi:10.1097/QAD.0000000000003865]

  • Martin-Mateos R, Martínez-Arenas L, Carvalho-Gomes Á, Aceituno L, Cadahía V, Salcedo MM, Arias A, Pérez SL, Odriozola A, Zamora J, Blanes M, Len Ó, Benítez L, Campos-Varela I, González Diéguez ML, Lázaro DR, Fortún J, Cuadrado A, Carrasco NM, Rodríguez-Perálvarez M, Navascues C, Fábrega E, Serrano T, Mons VC, Rodríguez M, Castells L, Berenguer M, Graus J, Albillos A.

    Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors.

    JOURNAL OF HEPATOLOGY . 80(6): 904-912. Nº de citas: 36

    [doi:10.1016/j.jhep.2024.02.023]

  • Moreno E, Ciordia S, Fátima SM, Jiménez D, Martínez-Sanz J, Vizcarra P, Ron R, Sánchez-Conde M, Bargiela R, Sanchez-Carrillo S, Moreno S, Corrales F, Ferrer M, Serrano-Villar S.

    Proteomic snapshot of saliva samples predicts new pathways implicated in SARS-CoV-2 pathogenesis.

    Clinical Proteomics . 21(1): 37-37. Nº de citas: 7

    [doi:10.1186/s12014-024-09482-9]

  • Fernández-Ruiz M, Gioia F, Bodro M, Gutiérrez Martín I, Sabé N, Rodriguez-Álvarez R, Corbella L, López-Viñau T, Valerio M, Illaro A, Salto-Alejandre S, Cordero E, Arnaiz de Las Revillas F, Fariñas MC, Muñoz P, Vidal E, Carratalà J, Goikoetxea J, Ramos-Martínez A, Moreno A, Martín-Dávila P, Fortún J, Aguado JM.

    Isavuconazole Versus Voriconazole as the First-line Therapy for Solid Organ Transplant Recipients With Invasive Aspergillosis: Comparative Analysis of 2 Multicenter Cohort Studies.

    TRANSPLANTATION . 108(11): 2260-2269. Nº de citas: 7

    [doi:10.1097/TP.0000000000005082]

  • Suárez-Robles M, Crespillo Andújar C, Chamorro-Tojeiro S, Monge-Maillo B, Norman F, Peña I, Corral M, Arcas C, Moreno S, Pérez-Molina JA.

    Real-life application of a stratification model for HIV care.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.) . : . Nº de citas: 1

    [doi:10.1016/j.eimce.2024.05.008]

  • Machado M, Fortún J, Muñoz P.

    Invasive aspergillosis: A comprehensive review.

    MEDICINA CLINICA . 163(4): 189-198. Nº de citas: 31

    [doi:10.1016/j.medcli.2024.01.045]

  • Trullàs JC, Peláez AI, Blázquez J, Sánchez-Biosca A, López-Reborio ML, Salamanca-Bautista P, Fernández-Rodríguez JM, Vázquez-Ronda MÁ, Dávila-Ramos MF, Mendoza-Ruiz-De-Zuazu H, Morales-Rull JL, Olmedo-Llanes J, Llàcer P, Conde-Martel A.

    The significance of metabolic alkalosis on acute decompensated heart failure: the ALCALOTIC study.

    Clinical Research in Cardiology . 113(8): 1251-1262. Nº de citas: 7

    [doi:10.1007/s00392-024-02452-z]

  • Salamanca-Rivera E, Palacios-Baena ZR, Cañada JE, Moure Z, Pérez-Vázquez M, Calvo-Montes J, Martínez-Martínez L, Cantón R, Ruiz Carrascoso G, Pitart C, Navarro F, Bou G, Mulet X, González-López JJ, Sivianes F, Delgado-Valverde M, Pascual Á, Oteo-Iglesias J, Rodríguez-Baño J.

    Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain.

    INFECTION . 52(6): 2231-2240. Nº de citas: 8

    [doi:10.1007/s15010-024-02267-0]

  • Norman FF, Gonzalez-Sanz M.

    Pulmonary infections in the returning traveler.

    CURRENT OPINION IN PULMONARY MEDICINE . 30(3): 243-251. Nº de citas: 1

    [doi:10.1097/MCP.0000000000001051]

  • Salmanton-García J, Bruns C, Rutz J, Albertsmeier M, Ankert J, Bernard L, Bataille C, Couvé-Deacon E, Fernández-Ferrer M, Fortún J, Galar A, Grill E, Guimard T, Classen AY, Vehreschild JJ, Stemler J, Naendrup JH, Hampl J, Tallon B, Sprute R, Horcajada JP, Mollar-Maseres J, Muñoz P, Pletz MW, Serracino-Inglott F, Soriano A, Vilz TO, Seifert H, Cornely OA, Mellinghoff SC, Liss BJ, Wingen-Heimann SM.

    Costs and resource utilization patterns in surgical site infections: A pre-COVID-19 perspective from France, Germany, Spain, and the United Kingdom.

    Journal of Hospital Infection . 147: 123-132. Nº de citas: 5

    [doi:10.1016/j.jhin.2024.02.019]